BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3994204)

  • 1. Imidazoles, ketoconazole, amphotericin B, and Candida guilliermondii.
    Wilson G; Peacock JE
    Ann Intern Med; 1985 Jun; 102(6):866. PubMed ID: 3994204
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
    Siavoshi F; Tavakolian A; Foroumadi A; Hosseini NM; Massarrat S; Pedramnia S; Saniee P
    Arch Iran Med; 2012 Jan; 15(1):27-31. PubMed ID: 22208440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):185-7. PubMed ID: 6299182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi F; Tortorano AM; Di Francesco LF; Cogliati M; Scalise G; Viviani MA
    J Antimicrob Chemother; 1999 Feb; 43(2):295-9. PubMed ID: 11252339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN; Chandy R; Khan ZU
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
    Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
    FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
    Ozkutuk A; Ergon C; Yulug N
    J Chemother; 2002 Dec; 14(6):640-1. PubMed ID: 12583561
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method.
    Giri S; Kindo AJ
    Indian J Pathol Microbiol; 2014; 57(4):595-7. PubMed ID: 25308014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
    Eng RH; Person A; Mangura C; Chmel H; Corrado M
    Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S; Pyun MS
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
    Birinci A; Saniç A; Durupinar B
    J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J
    Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole resistance.
    Lancet; 1982 Oct; 2(8301):770-1. PubMed ID: 6125840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antimycotic effect of chlorotritylimidazole on Candida and Cryptococcus neoformans].
    Ritzerfeld W; Weisbrod W
    Arzneimittelforschung; 1972 Dec; 22(12):2073-5. PubMed ID: 4575345
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the in vitro sensitivity of Candida albicans to nystatin, trichomycin, amphotericin B and gentian violet].
    Simon C; Tabrizi SA
    Med Welt; 1967 Sep; 37():2164-8. PubMed ID: 5629382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.